-
-
-
-
-
-
-
Barclays Starts Merck (MRK) at Overweight
-
-
-
-
-
-
-
FDA approves Merck's (MRK) Keytruda for platinum-resistant ovarian cancer patients
-
-
-
-
-
-
-
Merck (MRK) PT Raised to $135 at BMO Capital
-
-
-
-
-
-
-
Merck (MRK) call put ratio 1.7 calls to 1 put into quarter results
-
-
-
-
-
-
-
Merck (MRK) Added to BofA US 1 List, Apple (AAPL) Remains On
-
-
-
-
-
-
-
Merck (MRK) Reiterated at Buy by UBS: Bags FDA CNPV Voucher for Sac-TMT
-
-
-
-
-
-
-
Merck (MRK) in Talks to buy Revolution Medicines (RVMD) - FT
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

